🔎 Trials Near Me

홈 › 자가면역질환 › 노스캐롤라이나

노스캐롤라이나의 자가면역질환 임상 시험

자가면역질환 관련 연구 20개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

노스캐롤라이나의 도시

공식 연구 텍스트(영어)

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1020, Chapel Hill
  • Site Number - 1013, Durham
  • Site Number - 1044, Raleigh
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07039916

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
  • Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
피험자 모집 중2/3상
6세 ~ 75세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06154252

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  • Duke University Medical Center, Durham
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06056297

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • On Site Clinical Solutions Llc, Charlotte
  • Carolina Arthritis Associates, Wilmington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07621809

Study of PTC844 in Participants With Active Rheumatoid Arthritis

  • DJL Clinical Research PLLC, Charlotte
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07779616

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Duke University Hospital, Durham
  • East Carolina University, Greenville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06722235

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Atrium Health Rheumatology-Southpark, Charlotte
  • Duke University Medical Center, Durham
피험자 모집 중1상
18세 ~ 74세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07085104

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Duke University Hospital, Durham
  • East Carolina University, Greenville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06948318

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

  • Site 113, Wilmington
피험자 모집 중1상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07885605

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  • East Carolina University, Greenville
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07059000

Daratumumab in Primary Antiphospholipid Syndrome

  • Duke University, Durham
피험자 모집 중1/2상
18세 ~ 65세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05671757

Environmental Risk Factors for the Anti-synthetase Syndrome

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
피험자 모집 중관찰 연구건강한 지원자 환영
2세 ~ 100세 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT01276470

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Duke University, Durham
피험자 모집 중2/3상
18세 ~ 75세 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT06328777

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • UNC Chapel Hill, Chapel Hill
피험자 모집 중1/2상
12세 ~ 65세 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT06121297

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06572384

Study of BHV-1300 in Graves' Disease

  • Site-108, Greenville
피험자 모집 중1상
18세 ~ 65세 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06980649

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Duke University, Durham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT07115745

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Levine Children's Hospital, Charlotte
  • Duke University Medical Center, Durham
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Duke University Health System, Durham
피험자 모집 중1상
12세 ~ 70세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06308978

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

  • Duke University, Durham
피험자 모집 중관찰 연구건강한 지원자 환영
전 연령 · 여성 · 2026. 1. 8. 업데이트됨 · NCT03276923

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.